{
  "case_id": "EI08-7681",
  "year": 2008,
  "patient_info": {
    "age_range": "41 to 50",
    "gender": "Male"
  },
  "diagnosis": "Immuno Disorders",
  "secondary_conditions": [],
  "complications": [],
  "symptoms": [],
  "treatment_category": "Special Proc",
  "treatment_subcategory": "Stem Cell Transplant",
  "treatments_requested": [
    {
      "name": "High-dose Chemotherapy with Stem Cell Transplant",
      "drug_type": null,
      "procedure_type": "other",
      "is_procedure": true,
      "other_or_notes": "Experimental/Investigational"
    }
  ],
  "treatments_tried_but_failed": [
    {
      "name": "Standard Autoimmune Therapy",
      "drug_type": "standard",
      "procedure_type": null,
      "is_procedure": false,
      "other_or_notes": null
    }
  ],
  "treatments_tried_and_worked": [],
  "treatments_not_tried": [],
  "is_denial_upheld": false,
  "issues_considered": [
    "medical_necessity",
    "plan_coverage"
  ],
  "other_issues": null,
  "guidelines_support": null,
  "guidelines_not_support": null,
  "guidelines_details": null,
  "soc_support": null,
  "soc_not_support": null,
  "soc_details": null,
  "study_support": true,
  "study_details": [
    {
      "study_name": "Literature support for autologous stem cell transplant",
      "study_authors": "Not specified",
      "key_findings": "Autologous stem cell transplant is a more encouraging alternative for patients refractory to traditional treatments for autoimmune disease."
    }
  ],
  "key_questions": [
    "medical_necessity",
    "plan_coverage"
  ],
  "expedited": true,
  "rationale": "The patient's severe, progressive autoimmune disease has not responded to standard therapies. Literature supports the requested treatment as a viable alternative for refractory cases, with no reasonable alternatives available.",
  "reviewer_credentials": null
}